FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

Neurolumen Provides Natural Alternative For Multiple Sclerosis Drugs


























Neurolumen offers a natural alternative option to pharmaceuticals for multiple sclerosis and other conditions. The device is FDA approved and covered by Medicare payments.

Oklahoma City, OK – 13 AUGUST, 2015 – Neurolumen LLC and Shelly Henry are pleased to announce that the company has developed a product which is proving to be an effective natural alternative to traditional medical techniques for working with multiple sclerosis patients. Drugs and therapeutic techniques commonly prescribed by medical doctors can quickly deplete the bank account of a patient and often doesn't do much to help the patient physically. The Neurolumen medical device requires only a few minutes daily, but the results are amazing.

One user, Christian, describes his experience with the device at https://youtu.be/DupE9zM9Qcg. “I use the Neurolumen device while relaxing comfortably in my own home. It is painless to use and allows me to again play physical games with my child. My doctors are astonished at the change in my condition. It has given me improved mobility and freedom from pain.”

The FDA-approved device is designed to deliver two different types of healing energy to tissues which are damaged through injuries or disease. Neurolumen combines both electrical stimulation and light therapy to the tissues. This combination is more effective than either technique used separately. The device allows for the elimination of pain medication for many patients. Pharmaceuticals can be harmful to the body, especially if taken over lengthy periods.

Neurolumen developer Shelly Henry designed the unit to help the recovery of her own daughter who suffered from chronic pain, following an automobile accident. Daughter Kara found relief from her full-body pain after only a short session with the medical device. Its use is currently being explored by the Veterans Administration as part of the therapy for various conditions.

More details regarding Neurolumen and its effectiveness can be viewed at http://abc13.com/health/miracle-treatments-end-womans-$100k-month-addiction/392108/ and http://www.neurolumen.com/images/RD_Story_small.pdf

Media Contact
Company Name: Neurolumen LLC
Contact Person: Shelly Henry
Email: CustomerService@Neurolumen.com
Phone: (405) 463-6525
Address:9636 N. May Ave., Suite 230
City: Oklahoma City
State: OK
Country: United States
Website: http://www.neurolumen.com

Story Source: The above story is based on materials provided by DIGITALJOURNAL
Note: Materials may be edited for content and length


Go to Newer News Go to Older News